Colgate to Aid by Innovation & Other Efforts: Should You Buy or Hold?

Colgate-Palmolive (CL) reported solid Q1 2025 results, exceeding Zacks Consensus Estimates with both earnings and revenue growth, driven by innovation and pricing strategies. The company maintains its leadership in the toothpaste and manual toothbrush markets with 40.9% and 31.9% global market share, respectively. While management projects low single-digit net sales growth and 2-4% organic sales growth for 2025, the outlook is tempered by macroeconomic headwinds, including inflation, tariffs, and unfavorable currency exchange rates, potentially impacting margins.

Analysis

Colgate-Palmolive (CL) demonstrated resilience in its Q1 2025 performance, surpassing Zacks Consensus Estimates for both revenue and earnings, primarily driven by strategic pricing actions and ongoing innovation. The company solidified its market dominance, commanding a 40.9% global market share in toothpaste and 31.9% in manual toothbrushes year-to-date. This performance was supported by a 1.4% organic sales increase in Q1 2025, fueled by a 1.5% pricing improvement, which also contributed to an 80 basis point expansion in gross margin and a 120 basis point rise in operating margin year-over-year. Management's focus on premiumization, exemplified by the re-launch of Colgate Total and Hill's Science Diet, and a significant $2 billion investment in its U.S. supply chain over five years, underscore its proactive strategies. However, the company faces considerable headwinds, including persistent macroeconomic uncertainty, inflationary pressures on raw materials, tariff concerns, and an anticipated low-single-digit negative impact from unfavorable currency exchange rates on 2025 sales. Despite these challenges, management projects low single-digit net sales growth and 2-4% organic sales growth for 2025, with earnings per share expected to grow in the low single digits, though the non-GAAP (Base Business) gross profit margin is anticipated to be nearly flat. The stock's 3.2% gain over the past three months, outperforming the industry's 0.7% rise, reflects some investor confidence amidst these mixed signals, while its Zacks Rank #3 (Hold) suggests a neutral short-term outlook.

Key Decisions for Investors

• Investors should consider Colgate-Palmolive's proven ability to drive organic sales through pricing and innovation against the backdrop of guided nearly flat gross margins and persistent macroeconomic headwinds, warranting a cautious but watchful stance consistent with its Hold rating.
• Key areas to monitor include the impact of raw material inflation, higher SG&A and advertising expenses, and currency fluctuations on profitability, alongside the efficacy of its supply chain investments and innovation pipeline in sustaining market share.
• Given the projected low single-digit EPS growth for 2025, investors should evaluate if this aligns with their return expectations, considering the company's defensive characteristics versus potential impacts from consumer uncertainty and tariff developments.